Acquisition Momentum Algorics was acquired by Precision for Medicine in March 2024, signaling a strong consolidation in biomarker-driven clinical research capabilities and potential cross-sell opportunities across Precision for Medicine’s global client base.

Biomarker Focus Being part of a biomarker-driven organization positions sales conversations around precision medicine, offering scopes for expanding clinical data services, lab translational work, and biomarker integration across trial design and execution.

Global Reach Precision for Medicine operates in 40 locations across North America, Europe, and Asia-Pacific with a 3,500-person workforce, providing a ripe environment for expanding Algorics supported offerings to multinational clients.

Tech Stack Synergy Utilize the existing tech stack including Alteryx, Tableau, and data-centric platforms to upsell data analytics, reporting automation, and integrated data intelligence services to current and prospective customers.

Growth & Leadership Recent leadership hires and office expansions in 2025 2026 indicate ongoing investment and growth, presenting opportunities to position Algorics-backed capabilities alongside new clinical development leadership and regional offices.